In order to explore potential inhibitor of PCa and validate the value of FOXM1-NEIL3 regulatory axis as therapy target, we utilized CMap algorithm to uncover small molecular inhibitors of the axis. This evidence concerns the gene FOXM1 and posterior cortical atrophy.